Are You Interested in Starting Your Own Health Related Home Based Business? Please Click Here to Find Out How!

The European Commission has approved Exelon patch (rivastigmine transdermal patch), an innovative way to deliver this effective medicine to patients suffering from mild to moderately severe Alzheimer’s disease. Exelon patch is the first and only transdermal treatment for Alzheimer’s disease, a degenerative brain disorder affecting 18 million people worldwide and the third leading cause of death behind cardiovascular disease and cancer3. [click link for full article]

More: continued here